SCHEMBL300896

SCHEMBL300896

COc1ccccc1-n1c(=O)[nH]c2c(C(N)=O)nc(N(C)[C@H]3CCCN3)nc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.56
HPGD P15428 4/20 0.56
ALDH1A1 P00352 4/20 0.56
GLA P06280 2/20 0.54
GAA P10253 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
HSD17B10 Q99714 4/20 0.46
USP2 O75604 3/20 0.46
TSHR P16473 3/20 0.46
MAPK1 P28482 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
BRCA1 P38398 2/20 0.46
LMNA P02545 3/20 0.44
KMT2A Q03164 3/20 0.44
MAPT P10636 2/20 0.43
MEN1 O00255 2/20 0.42
RXFP1 Q9HBX9 2/20 0.42
ESR1 P03372 1/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL301230 1.00 KDM4E (0.56) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL27988321 1.00 KDM4E (0.56) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL27960617 0.84 CSNK2A1 (0.56) KDM4EHPGDALDH1A1GAAHSD17B10
SCHEMBL27960609 0.84 CSNK2A1 (0.56) KDM4EHPGDALDH1A1GAAHSD17B10
SCHEMBL28298239 0.82 MAPT (0.38) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL28298243 0.82 MAPT (0.38) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL28299546 0.82 MAPT (0.38) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL300882 0.79 LMNA (0.69) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL300897 0.79 KDM4E (0.57) KDM4EHPGDALDH1A1GLAGAA
SCHEMBL300898 0.79 KDM4E (0.57) KDM4EHPGDALDH1A1GLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078018-B1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARM LLC (US) 2012-03-14 EP claimed
CN-104271139-A Treatment of cancer with tor kinase inhibitors SIGNAL PHARM LLC 2015-01-07 CN disclosed
CN-104271138-A Treatment of cancer with tor kinase inhibitors SIGNAL PHARM LLC 2015-01-07 CN disclosed